Skip to content
10-K

Annual Report

REMEDENT, INC.

0001144204-19-033068

← back to feed
Filed
Jun 28, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · Jun 28, 2019 20M sh
Shares Diluted FY 2019 · Mar 31, 2018 20M sh
Operating Cash Flow FY 2019 · Mar 31, 2018 $20.33K
Cash And Equivalents FY 2019 · Mar 31, 2018 $92.88K
Cash And Equivalents FY 2019 · Mar 31, 2017 $147.11K
Stockholders Equity FY 2019 · Mar 31, 2018 $3.23M
Current Liabilities FY 2019 · Mar 31, 2018 $2.13M
Current Assets FY 2019 · Mar 31, 2018 $1.67M
Total Assets FY 2019 · Mar 31, 2018 $5.44M
Eps Diluted FY 2019 · Mar 31, 2018 $0.00
Eps Basic FY 2019 · Mar 31, 2018 $0.00
Sga Expense FY 2019 · Mar 31, 2018 $1.06M
Rd Expense FY 2019 · Mar 31, 2018 $1.86K
Net Income FY 2019 · Mar 31, 2018 −$54.59K
Operating Income FY 2019 · Mar 31, 2018 −$300.76K
Gross Profit FY 2019 · Mar 31, 2018 $1.78M
Cost Of Revenue FY 2019 · Mar 31, 2018 $917.92K
Revenue FY 2019 · Mar 31, 2018 $2.7M